SEC Form 4 · accession 0001179110-17-014381
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geno J Germano
Director
Period of report
Nov 9, 2017
Accepted (ET)
Nov 20, 2017 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Call Option (right-to-buy)F1 | $30.90 | Nov 9, 2017 | A | 27,243 | A | — | Nov 9, 2027 | Common Stock | 27,243 | 27,243 | D |
Explanation of responses
- F1This option vests in one installment on November 9, 2020 and is made part of and pursuant to Issuer's director compensation package.